TY - JOUR AU - Tostmann, A. AU - Boeree, M. J. AU - Aarnoutse, R. E. AU - de Lange, W. C. M. AU - Ven, A. J. A. M. AU - Dekhuijzen, R. PY - 2008 DA - 2008// TI - Antituberculosis drug-induced hepatotoxicity: concise up-to-date review JO - J Gastroenterol Hepatol VL - 23 UR - https://doi.org/10.1111/j.1440-1746.2007.05207.x DO - 10.1111/j.1440-1746.2007.05207.x ID - Tostmann2008 ER - TY - JOUR AU - Singanayagam, A. AU - Sridhar, S. AU - Dhariwal, J. AU - Abdel-Aziz, D. AU - Munro, K. AU - Connell, D. W. AU - George, P. M. AU - Molyneaux, P. L. AU - Cooke, G. S. AU - Burroughs, A. K. AU - Lalvani, A. AU - Wickremasinghe, M. AU - Kon, O. M. PY - 2012 DA - 2012// TI - A Comparison between Two Strategies for Monitoring Hepatic Function during Antituberculous Therapy JO - Am J Respir Crit Care Med VL - 185 UR - https://doi.org/10.1164/rccm.201105-0850OC DO - 10.1164/rccm.201105-0850OC ID - Singanayagam2012 ER - TY - JOUR AU - Yimer, G. AU - Gry, M. AU - Amogne, W. AU - Makonnen, E. AU - Habtewold, A. AU - Petros, Z. AU - Aderaye, G. AU - Schuppe-Koistinen, I. AU - Lindquist, L. AU - Aklillu, E. PY - 2014 DA - 2014// TI - Evaluation of patterns of liver toxicity in patients on antiretroviral and anti-tuberculosis drugs: a prospective four arm observational study in ethiopian patients JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0094271 DO - 10.1371/journal.pone.0094271 ID - Yimer2014 ER - TY - JOUR AU - Yew, W. W. AU - Leung, C. C. PY - 2006 DA - 2006// TI - Antituberculosis drugs and hepatotoxicity JO - Respirology VL - 11 UR - https://doi.org/10.1111/j.1440-1843.2006.00941.x DO - 10.1111/j.1440-1843.2006.00941.x ID - Yew2006 ER - TY - JOUR AU - Hosford, J. D. AU - Fricken, M. E. AU - Lauzardo, M. AU - Chang, M. AU - Dai, Y. AU - Lyon, J. A. AU - Shuster, J. AU - Fennelly, K. P. PY - 2015 DA - 2015// TI - Hepatotoxicity from antituberculous therapy in the elderly: a systematic review JO - Tuberculosis (Edinb) VL - 95 UR - https://doi.org/10.1016/j.tube.2014.10.006 DO - 10.1016/j.tube.2014.10.006 ID - Hosford2015 ER - TY - JOUR AU - Wang, N. -. T. AU - Huang, Y. -. S. AU - Lin, M. -. H. AU - Huang, B. AU - Perng, C. -. L. AU - Lin, H. -. C. PY - 2016 DA - 2016// TI - Chronic hepatitis B infection and risk of antituberculosis drug-induced liver injury: Systematic review and meta-analysis JO - J Chinese Med Assoc VL - 79 UR - https://doi.org/10.1016/j.jcma.2015.12.006 DO - 10.1016/j.jcma.2015.12.006 ID - Wang2016 ER - TY - JOUR AU - Kim, W. S. AU - Lee, S. S. AU - Lee, C. M. AU - Kim, H. J. AU - Ha, C. Y. AU - Kim, H. J. PY - 2016 DA - 2016// TI - Hepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury JO - BMC Infect Dis VL - 16 UR - https://doi.org/10.1186/s12879-016-1344-2 DO - 10.1186/s12879-016-1344-2 ID - Kim2016 ER - TY - JOUR AU - Bright-Thomas, R. J. AU - Gondker, A. R. AU - Morris, J. AU - Ormerod, L. P. PY - 2016 DA - 2016// TI - Drug-related hepatitis in patients treated with standard anti-tuberculosis chemotherapy over a 30-year period JO - Int J Tuberc Lung Dis VL - 20 UR - https://doi.org/10.5588/ijtld.16.0370 DO - 10.5588/ijtld.16.0370 ID - Bright-Thomas2016 ER - TY - STD TI - Danan G, Teschke R. RUCAM in Drug and Herb Induced Liver Injury: The Update. Int J Mol Sci. 2016;17(1):14. doi:10.3390/ijms17010014. ID - ref9 ER - TY - JOUR AU - Teschke, R. AU - Danan, G. PY - 2016 DA - 2016// TI - Diagnosis and Management of Drug-Induced Liver Injury (DILI) in Patients with Pre-Existing Liver Disease JO - Drug Saf VL - 39 UR - https://doi.org/10.1007/s40264-016-0423-z DO - 10.1007/s40264-016-0423-z ID - Teschke2016 ER - TY - STD TI - Teschke R, Danan G. Drug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue? Expert Opin Drug Metab Toxicol. 2016;1–14. http://dx.doi.org/10.1080/17425255.2017.1252749. UR - http://dx.doi.org/10.1080/17425255.2017.1252749 ID - ref11 ER - TY - JOUR AU - Aithal, G. P. AU - Watkins, P. B. AU - Andrade, R. J. AU - Larrey, D. AU - Molokhia, M. AU - Takikawa, H. AU - Hunt, C. M. AU - Wilke, R. A. AU - Avigan, M. AU - Kaplowitz, N. AU - Bjornsson, E. AU - Daly, A. K. PY - 2011 DA - 2011// TI - Case definition and phenotype standardization in drug-induced liver injury JO - Clin Pharmacol Ther VL - 89 UR - https://doi.org/10.1038/clpt.2011.58 DO - 10.1038/clpt.2011.58 ID - Aithal2011 ER - TY - STD TI - Sonika U, Kar P. Tuberculosis and liver disease: management issues. Trop Gastroenterol. 2012;33(2):102–6. Available at: https://www.ncbi.nlm.nih.gov/pubmed/23025055. UR - https://www.ncbi.nlm.nih.gov/pubmed/23025055 ID - ref13 ER - TY - STD TI - Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, Peloquin CA, Gordin FM, Nunes D, Strader DB, Bernardo J, Venkataramanan R, Sterling TR. ATS (American Thoracic Society) Hepatotoxicity of Antituberculosis Therapy Subcommittee. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006;174(8):935–52. Available at: https://www.ncbi.nlm.nih.gov/pubmed/17021358. UR - https://www.ncbi.nlm.nih.gov/pubmed/17021358 ID - ref14 ER - TY - STD TI - Mitchell JR, Zimmerman HJ, Ishak KG, Thorgeirsson UP, Timbrell JA, Snodgrass WR, Nelson SD. Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. Ann Intern Med. 1976;84(2):181–92. Available: https://www.ncbi.nlm.nih.gov/pubmed/766682. UR - https://www.ncbi.nlm.nih.gov/pubmed/766682 ID - ref15 ER - TY - JOUR AU - Scharer, L. PY - 1969 DA - 1969// TI - Serum Transaminase Elevations and Other Hepatic Abnormalities in Patients Receiving Isoniazid JO - Ann Intern Med VL - 71 UR - https://doi.org/10.7326/0003-4819-71-6-1113 DO - 10.7326/0003-4819-71-6-1113 ID - Scharer1969 ER - TY - STD TI - Devarbhavi H1, Singh R, Patil M, Sheth K, Adarsh CK, Balaraju G. Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury. J Gastroenterol Hepatol. 2013;28(1):161–7. doi:10.1111/j.1440-1746.2012.07279.x. Available at: https://www.ncbi.nlm.nih.gov/pubmed/23020522. UR - https://www.ncbi.nlm.nih.gov/pubmed/23020522 ID - ref17 ER - TY - JOUR AU - Schutz, C. AU - Ismail, Z. AU - Proxenos, C. J. AU - Marais, S. AU - Burton, R. AU - Kenyon, C. AU - Maartens, G. AU - Wilkinson, R. J. AU - Meintjes, G. PY - 2012 DA - 2012// TI - Burden of antituberculosis and antiretroviral drug-induced liver injury at a secondary hospital in South Africa JO - S Afr Med J VL - 102 UR - https://doi.org/10.7196/SAMJ.5650 DO - 10.7196/SAMJ.5650 ID - Schutz2012 ER - TY - STD TI - “Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society”. Thorax 1998; 53(7), 536–48. ID - ref19 ER - TY - JOUR AU - Migliori, G. B. AU - Raviglione, M. C. AU - Schaberg, T. AU - Davies, P. D. AU - Zellweger, J. P. AU - Grzemska, M. AU - Mihaescu, T. AU - Clancy, L. AU - Casali, L. PY - 1999 DA - 1999// TI - Tuberculosis management in Europe. Task Force of the European Respiratory Society (ERS), the World Health Organisation (WHO) and the International Union against Tuberculosis and Lung Disease (IUATLD) Europe Region JO - Eur Respir J VL - 14 UR - https://doi.org/10.1183/09031936.99.14497899 DO - 10.1183/09031936.99.14497899 ID - Migliori1999 ER - TY - STD TI - Daly AK1, Donaldson PT, Bhatnagar P, Shen Y, Pe'er I, Floratos A, Daly MJ, Goldstein DB, John S, Nelson MR, Graham J, Park BK, Dillon JF, Bernal W, Cordell HJ, Pirmohamed M, Aithal GP, Day CP. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. DILIGEN Study; International SAE Consortium. Nat Genet. 2009;41(7):816–9. doi:10.1038/ng.379. Epub 2009 May 31. Available at: https://www.ncbi.nlm.nih.gov/pubmed/19483685. UR - https://www.ncbi.nlm.nih.gov/pubmed/19483685 ID - ref21 ER - TY - JOUR AU - Ormerod, L. P. AU - Skinner, C. AU - Wales, J. PY - 1996 DA - 1996// TI - Hepatotoxicity of antituberculosis drugs JO - Thorax VL - 51 UR - https://doi.org/10.1136/thx.51.2.111 DO - 10.1136/thx.51.2.111 ID - Ormerod1996 ER - TY - STD TI - American Thoracic Society, CDC, and Infectious Diseases Society of America. “Treatment of Tuberculosis American Thoracic Society, CDC, and Infectious Diseases Society of America,” American Journal of Respiratory and Critical Care Medicine, 2003. [Online]. Available: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5211a1.htm. UR - https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5211a1.htm ID - ref23 ER - TY - JOUR AU - Gülbay, B. E. AU - Gürkan, Ö. U. AU - Yıldız, Ö. A. AU - Önen, Z. P. AU - Erkekol, F. Ö. AU - Baççıoğlu, A. AU - Acıcan, T. PY - 2006 DA - 2006// TI - Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis JO - Respir Med VL - 100 UR - https://doi.org/10.1016/j.rmed.2006.01.014 DO - 10.1016/j.rmed.2006.01.014 ID - Gülbay2006 ER - TY - JOUR AU - Sharifzadeh, M. AU - Rasoulinejad, M. AU - Valipour, F. AU - Nouraie, M. AU - Vaziri, S. PY - 2005 DA - 2005// TI - Evaluation of patient-related factors associated with causality, preventability, predictability and severity of hepatotoxicity during antituberculosis [correction of antituberclosis] treatment JO - Pharmacol Res VL - 51 UR - https://doi.org/10.1016/j.phrs.2004.10.009 DO - 10.1016/j.phrs.2004.10.009 ID - Sharifzadeh2005 ER - TY - JOUR AU - Babalık, A. AU - Arda, H. AU - Bakırcı, N. AU - Ağca, S. AU - Oruç, K. AU - Kızıltaş, S. AU - Cetintaş, G. AU - Calışır, H. C. PY - 2012 DA - 2012// TI - Management of and risk factors related to hepatotoxicity during tuberculosis treatment JO - Tuberk Toraks VL - 60 UR - https://doi.org/10.5578/tt.3053 DO - 10.5578/tt.3053 ID - Babalık2012 ER - TY - JOUR AU - Kada, H. M. AU - Munteanu, M. AU - Perazzo, H. AU - Ngo, Y. AU - Ramanujam, N. AU - Imbert-bismut, F. AU - Ratziu, V. AU - Bonnefont-rousselot, D. AU - Souberbielle, B. AU - Schuppe-koistinen, I. AU - Poynard, T. PY - 2011 DA - 2011// TI - What are the best reference values for a normal serum alanine transaminase activity ( ALT )? Impact on the presumed prevalence of drug induced liver injury ( DILI ) JO - Regul Toxicol Pharmacol VL - 60 UR - https://doi.org/10.1016/j.yrtph.2011.04.002 DO - 10.1016/j.yrtph.2011.04.002 ID - Kada2011 ER - TY - JOUR AU - Devarbhavi, H. PY - 2012 DA - 2012// TI - An Update on Drug-induced Liver Injury JO - J Clin Exp Hepatol VL - 2 UR - https://doi.org/10.1016/j.jceh.2012.05.002 DO - 10.1016/j.jceh.2012.05.002 ID - Devarbhavi2012 ER - TY - STD TI - An H, Wu X, Wang Z, Xu J, Zheng S, Wang K. The clinical characteristics of anti-tuberculosis drug induced liver injury in 2457 hospitalized patients with tuberculosis in China . Afr. J. Pharm. Pharmacol. 2013;7(13):710–14. doi:10.5897/AJPP2013.2963. http://www.academicjournals.org/journal/AJPP/article-full-text-pdf/B40DBF628217. UR - http://www.academicjournals.org/journal/AJPP/article-full-text-pdf/B40DBF628217 ID - ref29 ER - TY - JOUR AU - Shang, P. AU - Xia, Y. AU - Liu, F. AU - Wang, X. AU - Yuan, Y. AU - Hu, D. AU - Tu, D. AU - Chen, Y. AU - Deng, P. AU - Cheng, S. AU - Zhou, L. AU - Ma, Y. AU - Zhu, L. AU - Gao, W. AU - Wang, H. AU - Chen, D. AU - Yang, L. AU - He, P. AU - Wu, S. AU - Tang, S. AU - Lv, X. AU - Shu, Z. AU - Zhang, Y. AU - Yang, Z. AU - Chen, Y. AU - Li, N. AU - Sun, F. AU - Li, X. AU - He, Y. AU - Garner, P. AU - Zhan, S. PY - 2011 DA - 2011// TI - Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0021836 DO - 10.1371/journal.pone.0021836 ID - Shang2011 ER - TY - JOUR AU - Chang, K. C. AU - Leung, C. C. PY - 2010 DA - 2010// TI - The best approach to reintroducing tuberculosis treatment after hepatotoxicity is still open to debate JO - Clin Infect Dis VL - 51 UR - https://doi.org/10.1086/654806 DO - 10.1086/654806 ID - Chang2010 ER - TY - STD TI - Chang KC1, Leung CC, Yew WW, Lau TY, Tam CM. Hepatotoxicity of pyrazinamide: cohort and case-control analyses. Am J Respir Crit Care Med. 2008;177(12):1391–6. doi:10.1164/rccm.200802-355OC. Epub 2008 Apr 3. Available at: https://www.ncbi.nlm.nih.gov/pubmed/18388355. UR - https://www.ncbi.nlm.nih.gov/pubmed/18388355 ID - ref32 ER - TY - STD TI - Jong E, Conradie F, Berhanu R, Black A, John M-A, Meintjes G, Menezes C. Consensus statement: Management of drug-induced liver injury in HIV-positive patients treated for TB. Southern African J HIV Med. 14(3):113–9. ID - ref33 ER - TY - JOUR AU - Sharma, S. K. AU - Singla, R. AU - Sarda, P. AU - Mohan, A. AU - Makharia, G. AU - Jayaswal, A. AU - Sreenivas, V. AU - Singh, S. PY - 2010 DA - 2010// TI - Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity JO - Clin Infect Dis VL - 50 UR - https://doi.org/10.1086/650576 DO - 10.1086/650576 ID - Sharma2010 ER - TY - JOUR AU - Agal, S. AU - Baijal, R. AU - Pramanik, S. AU - Patel, N. AU - Gupte, P. AU - Kamani, P. AU - Amarapurkar, D. PY - 2005 DA - 2005// TI - Monitoring and management of antituberculosis drug induced hepatotoxicity JO - J Gastroenterol Hepatol VL - 20 UR - https://doi.org/10.1111/j.1440-1746.2005.04048.x DO - 10.1111/j.1440-1746.2005.04048.x ID - Agal2005 ER - TY - JOUR AU - Gaude, G. S. AU - Chaudhury, A. AU - Hattiholi, J. PY - 2015 DA - 2015// TI - Drug-induced hepatitis and the risk factors for liver injury in pulmonary tuberculosis patients JO - J Fam Med Prim care VL - 4 UR - https://doi.org/10.4103/2249-4863.154661 DO - 10.4103/2249-4863.154661 ID - Gaude2015 ER - TY - JOUR AU - Chakravorty, S. AU - Sen, M. K. AU - Tyagi, J. S. PY - 2005 DA - 2005// TI - Diagnosis of extrapulmonary tuberculosis by smear, culture, and PCR using universal sample processing technology JO - J Clin Microbiol VL - 43 UR - https://doi.org/10.1128/JCM.43.9.4357-4362.2005 DO - 10.1128/JCM.43.9.4357-4362.2005 ID - Chakravorty2005 ER - TY - STD TI - “Tuberculosis, NICE guidelines 2016,” 2016. [Online]. Available: https://www.nice.org.uk/guidance/ng33/resources/tuberculosis-1837390683589. Accessed 17 Feb 2016. UR - https://www.nice.org.uk/guidance/ng33/resources/tuberculosis-1837390683589 ID - ref38 ER -